Neurimmune Holding is a biopharmaceutical company that focuses on developing immunotherapeutics to treat and prevent human disorders with high unmet medical needs. They use a unique platform called Reverse Translational Medicine\u2122 to create monoclonal antibodies that closely resemble those found in healthy elderly individuals. These antibodies have unique properties that make them effective an...